E. Schrinner
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
- Pharmacology 25
- Antibiotics Pharmacokinetics and Efficacy 22
-
- Antibiotic Resistance in Bacteria 18
- Co-authors
- M. Limbert (23 shared papers)Gerhard Seibert (24 shared papers)N. Klesel (20 shared papers)Irvin Winkler (11 shared papers)A. Markus (9 shared papers)K. Seeger (5 shared papers)J. BLUMBACH (3 shared papers)Klaus Fleischmann (3 shared papers)
- Journals
- The Journal of Antibiotics (14 papers)Infection (4 papers)Journal of Antimicrobial Chemotherapy (4 papers)Antimicrobial Agents and Chemotherapy (1 paper)AIDS (1 paper)
- Partner nations
- GermanyUnited StatesCroatia
In The Last Decade
E. Schrinner
34 papers receiving 490 citations
Peers
Comparison fields: 5 of 73
- Molecular Medicine 268
- Pharmacology 355
- Clinical Biochemistry 54
- Microbiology 46
- Infectious Diseases 124
Countries citing papers authored by E. Schrinner
This map shows the geographic impact of E. Schrinner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Schrinner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Schrinner more than expected).
Fields of papers citing papers by E. Schrinner
This network shows the impact of papers produced by E. Schrinner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Schrinner. The network helps show where E. Schrinner may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Schrinner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 98 | |
| 2 | 1977 | 58 | |
| 3 | 1980 | 43 | |
| 4 | 1983 | 34 | |
| 5 | 1988 | 33 | |
| 6 | 1984 | 29 | |
| 7 | 1988 | 26 | |
| 8 | 1992 | 25 | |
| 9 | 1982 | 22 | |
| 10 | 1984 | 21 | |
| 11 | 1984 | 21 | |
| 12 | 1984 | 21 | |
| 13 | 1987 | 17 | |
| 14 | 1992 | 15 | |
| 15 | 1992 | 12 | |
| 16 | [Microbiological laboratory studies with ciclopiroxolamine (author's transl)]. | 1981 | 12 |
| 17 | [The Candida infected hen's egg. An alternative test system for systemic anticandida activity]. | 1995 | 12 |
| 18 | The in vitro antimicrobial activity of desacetylcefotaxime compared to other related beta-lactams. | 1984 | 12 |
| 19 | 1987 | 9 | |
| 20 | 1984 | 8 |
About E. Schrinner
E. Schrinner is a scholar working on Pharmacology, Molecular Medicine, Molecular Biology, Infectious Diseases and Organic Chemistry, having authored 36 papers that have together received 579 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (22 papers), Antibiotic Resistance in Bacteria (18 papers), Phenothiazines and Benzothiazines Synthesis and Activities (7 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Drug Transport and Resistance Mechanisms (3 papers), HIV/AIDS drug development and treatment (3 papers), Antibiotic Use and Resistance (3 papers) and Bacterial Identification and Susceptibility Testing (3 papers). The work is most often cited by research in Molecular Medicine (268 citations), Pharmacology (355 citations), Clinical Biochemistry (54 citations), Microbiology (46 citations) and Infectious Diseases (124 citations). E. Schrinner has collaborated with scholars based in Germany, United States and Croatia. Frequent co-authors include M. Limbert, Gerhard Seibert, N. Klesel, Irvin Winkler, A. Markus, K. Seeger, J. BLUMBACH, Klaus Fleischmann, Helga Rübsamen‐Waigmann and Robert Bartlett. Their work appears in journals such as The Journal of Antibiotics, Infection, Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy and AIDS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.